Medicine composition for treating phlegm-heat obstructive pulmonary type asthma

Abstract

The invention relates to a medicine composition for treating phlegm-heat obstructive pulmonary type asthma. The medicine composition is prepared from the following traditional Chinese medicine raw materials in parts by weight: 3 to 5 parts of abutilon indicum, 5 to 7 parts of leontopodium longifolium ling, 8 to 15 parts of herba asteris ageratoidis, 3 to 7 parts of radix stephaniae dielsianae, 5 to 7 parts of clinopodium herb, 8 to 10 parts of lotus corniculatus, 5 to 8 parts of ficus hispida, 7 to 15 parts of lysimachia microcarpa, 3 to 7 parts of scirpus triangulatus roxb, 5 to 8 parts of morinda cochinchinensis DC, 8 to 15 parts of lobelia sessilifolia lamb, 3 to 7 parts of gentiana rubicunda, 3 to 5 parts of thysanolaena maxima, 5 to 15 parts of cabbage mustard, 10 to 15 parts of radix aster auriculatus franch and 10 to 15 parts of herb of blin conyza. The medicine composition provided by the invention has the effects of dispelling wind and clearing away heat, opening the lung and stopping cough, and relieving asthma and lowering the adverse flow of qi, has the accurate curative effect of treating phlegm-heat obstructive pulmonary type asthma and has high efficiency; phlegm-heat obstructive pulmonary type asthma is not easy to reoccur and the medicine composition has no toxic or side effect.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicines and relates to a pharmaceutical composition for treating asthma of phlegm-heat blocking lung type. Background technique [0002] Asthma is a chronic airway inflammatory disease involving a variety of cells and cellular components. This chronic inflammation is associated with airway hyperresponsiveness, usually with extensive and variable reversible airflow limitation, leading to recurrent wheezing, Symptoms such as shortness of breath, chest tightness, and (or) cough usually occur and intensify at night and (or) early morning, and most patients can relieve themselves or be relieved by treatment. [0003] Traditional Chinese medicine believes that the etiology of asthma has both exogenous pathogenic factors and internal injuries. Exogenous pathogenic factors: wind-cold, wind-heat attack, or allergies affected by smoke, paint, pollen, etc., can cause loss of lung qi and block airways; i...

AI Technical Summary

Problems solved by technology

[0005] At present, there are many drugs for the treatment of asthma, but they are highly dependent, have side effects, and are prone to relapse